Value of Gonadotropin-Releasing Hormone Testing in the Differential Diagnosis of Androgen Deficiency in Elderly Men
Authors:
Open Access
- 1 March 2005
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 90 (3) , 1280-1286
Abstract
Elderly men with low testosterone (T) levels are increasingly diagnosed to have partial androgen deficiency of the aging male (PADAM). Frequently, magnetic resonance imaging is performed to exclude pituitary adenoma. The value of GnRH testing to differentiate PADAM from secondary hypogonadism is unknown. Serum levels of T as well as LH and FSH at baseline and after GnRH were evaluated in the following groups: 1) 24 elderly men with low serum T (11.7 nmol/liter), 3) 10 men with primary hypogonadism, 4) 24 men with secondary hypogonadism, and 5) 13 healthy young volunteers. In elderly men, T levels were lower (P < 0.001) and gonadotropin levels higher (P = 0.03) compared with younger controls. LH and FSH response to GnRH was higher in elderly men with low T levels (PADAM) compared with elderly men with normal T levels (P = 0.02 and P < 0.001) in the presence of similar basal gonadotropin levels. To differentiate secondary hypogonadism from PADAM with a sensitivity of 100%, a T less than 10 nmol/liter had a specificity of 50%. This specificity was improved to 75% by using a cutoff of less than or equal to 15 mU/liter increase of LH upon GnRH stimulation. Overall, decreased T levels and increased LH levels in elderly men suggest a primary Leydig cell dysfunction. In the subgroup of elderly men with low T levels, an increased LH response to GnRH with normal basal LH levels suggests additional, possibly hypothalamic changes. To exclude secondary hypogonadism in PADAM, diagnostic accuracy can be improved by using GnRH testing.Keywords
This publication has 20 references indexed in Scilit:
- IS THERE A CLINICAL RELEVANCE OF PARTIAL ANDROGEN DEFICIENCY OF THE AGING MALE?Journal of Urology, 2004
- Hypogonadism in Elderly Men — What to Do Until the Evidence ComesNew England Journal of Medicine, 2004
- Luteinizing Hormone and Different Genetic Variants, as Indicators of Frailty in Healthy Elderly MenThe Journal of Clinical Endocrinology & Metabolism, 1999
- Serum testosterone and its relation to bone mineral density and body composition in normal malesClinical Endocrinology, 1995
- Androgens in the Aging MaleThe Journal of Clinical Endocrinology & Metabolism, 1991
- Influence of Age on the Responsiveness of the Gonadotrophs to Luteinizing Hormone-Releasing Hormone in Males*The Journal of Clinical Endocrinology & Metabolism, 1991
- The Pituitary "Incidentaloma"Annals of Internal Medicine, 1990
- Influence of Antiopioids on Luteinizing Hormone Pulsatility in Aging Men*The Journal of Clinical Endocrinology & Metabolism, 1989
- Decreased Bioavailable Testosterone in Aging Normal and Impotent Men*The Journal of Clinical Endocrinology & Metabolism, 1986
- Episodic Luteinizing Hormone (LH) Secretion and the Response of LH and Follicle-Stimulating Hormone to LH-Releasing Hormone in Aged Men: Evidence for Coexistent Primary Testicular Insufficiency and an Impairment in Gonadotropin Secretion*The Journal of Clinical Endocrinology & Metabolism, 1982